Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/31/13
End: 01/31/24
Due: 01/31/25
Phase: N/A
Priority: Normal
Start: 07/31/21
End: 06/30/26
Due: 06/30/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Vaccine Therapy for Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) | NCT01976520 | XEME Biopharma Inc. | user2@example.com | None | 2013-10-31 | 2024-01-31 | 2025-01-31 | - | - | 2025-07-14 |
| Oncoquest-L Vaccine in Patients With Previously Untreated Stage III or IV, Asymptomatic, Non-bulky Follicular Lymphoma | NCT02194751 | XEME Biopharma Inc. | user2@example.com | None | 2021-07-31 | 2026-06-30 | 2027-06-30 | - | - | 2025-07-14 |